Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with rheumatoid arthritis (RA) according to recognised medical classification guidelines, within 12 months of their first visit to an Early Arthritis Clinic
- People who started conventional arthritis medication (known as csDMARDs, such as methotrexate) within 12 months of their symptoms first appearing
- People who have been continuously taking conventional arthritis medication for at least 24 months
- People who have never used biologic or targeted synthetic arthritis medications (a more advanced type of treatment)
- People whose RA has been in a low-disease-activity state (meaning symptoms are well controlled) for at least 6 months, without the use of steroid medications
- People whose treating rheumatologist has agreed, through a shared decision-making process, to a plan of gradually reducing or stopping their arthritis medication with regular monitoring as part of their normal care
- People who are able to give written consent to participate in the registry
Who may not be able to join:
- People whose RA affects parts of the body beyond the joints (such as the lungs, eyes, or skin — confirm with trial site)
- People who have another ongoing chronic inflammatory or autoimmune condition affecting the joints or muscles, in addition to RA
- People with a personal history of psoriasis affecting the skin or nails
- People with serious heart or cardiovascular disease
- People with a severe physical disability that would make it difficult to follow the study procedures or attend follow-up appointments
- People with severe cognitive impairment (significant difficulties with memory or thinking)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antonio Manzo, MD PhD, University of Pavia/Fondazione IRCCS Policlinico San Matteo
Phone: +39 0382 501887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Longitudinal disease control
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.